THC Farmaceuticals, Inc.
CBDG · OTC
9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $4 | $1 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $4 | $1 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | 347.6% | -70.5% | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | – | 61.9% | 57.4% | 100% |
| EBITDA | -$0 | $0 | -$0 | -$0 |
| % Margin | – | 4,298.7% | -709.7% | -1,580.2% |
| Net Income | -$0 | $0 | -$0 | -$0 |
| % Margin | – | 4,269.1% | -376.9% | -798% |
| EPS Diluted | -0.001 | 0.024 | -0.001 | -0.004 |
| % Growth | -103.4% | 4,800% | 86.1% | – |
| Operating Cash Flow | $1 | $0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $1 | $0 | -$0 | -$0 |